Schrodinger Stock Quote SDGR - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

24.06

Bid

24.06

Ask

24.08

Volume

488,893

22.85 Day's Range 24.12

18.21 52 Week Range 56.47

Market Cap

1.649B

Previous Close

22.69

Open

23.02

Last Trade

24.07

Last Trade Time

15:17:24

Financial Volume

$ 11,444,057

VWAP

23.4081

Average Volume (3m)

732,410

Shares Outstanding

72,679,390

Dividend Yield

PE Ratio

42.39

Earnings Per Share (EPS)

0.56

Revenue

216.67M

Net Profit

40.72M

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.schrodinger.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was $22.69. Over the last year, Schrodinger shares have traded in a share price range of $ 18.21 to $ 56.47.

Schrodinger currently has 72,679,390 shares outstanding. The market capitalization of Schrodinger is $1.65 billion. Schrodinger has a price to earnings ratio (PE ratio) of 42.39.

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	3.02	14.3536121673	21.04	24.18	20.05	631024	21.63699067	CS
4	4.26	21.5151515152	19.8	24.18	18.21	719942	19.99228838	CS
12	-0.43	-1.75581870151	24.49	26.75	18.21	732410	21.94073427	CS
26	-3.69	-13.2972972973	27.75	33.63	18.21	798109	24.99516587	CS
52	-29.02	-54.6721929164	53.08	56.47	18.21	833442	29.6633208	CS
156	-43.81	-64.5498747606	67.87	71.89	15.85	781917	32.91494518	CS
260	-6.39	-20.9852216749	30.45	117	15.85	891128	45.99611848	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SILOSilo Pharma Inc	$ 2.3968 (124.00%)	156.48M
TKLFYoshitsu Company Ltd	$ 0.547 (78.61%)	300.88M
NAASNaaS Technology Inc	$ 4.36 (55.71%)	20.87M
LCFYLocafy Ltd	$ 4.95 (35.62%)	5.92M
PACBPacific Biosciences of California Inc	$ 2.155 (33.02%)	32.11M
CYNCYNGN Inc	$ 6.76 (-26.36%)	1.05M
AMIXAutonomix Medical Inc	$ 1.115 (-19.20%)	6.35M
NBSTWNewbury Street Acquisition Corporation	$ 0.090295 (-18.43%)	120
CMNDClearmind Medicine Inc	$ 1.828 (-17.66%)	2.2M
AEHLAntelope Enterprise Holdings Ltd	$ 4.27 (-17.41%)	405.65k
TKLFYoshitsu Company Ltd	$ 0.547 (78.61%)	300.88M
MAXNMaxeon Solar Technologies Ltd	$ 0.255 (12.33%)	207.37M
NVDANVIDIA Corporation	$ 126.10 (-1.82%)	171.02M
SILOSilo Pharma Inc	$ 2.3968 (124.00%)	156.48M
SQQQProShares UltraPro Short QQQ	$ 7.475 (0.20%)	115.87M